DELAWARE
|
33-0824714
|
(State
of jurisdiction of Incorporation)
|
(I.R.S.
Employer Identification No.)
|
|
|
8885
REHCO RD.SAN DIEGO CA
|
92121
|
(Address
of principal executive offices)
|
(Zip
Code)
|
PART
I
|
ITEM
1.
|
3
|
|
|
|
|
ITEM
2.
|
10
|
|
|
|
|
ITEM
3.
|
11
|
|
|
|
|
ITEM
4.
|
11
|
PART
II
|
ITEM
5.
|
11
|
|
|
|
|
ITEM
6.
|
12
|
|
|
|
|
ITEM
7.
|
13
|
|
|
|
|
ITEM
8.
|
29
|
PART
III
|
ITEM
9.
|
30
|
|
|
|
|
ITEM
10.
|
37
|
|
|
|
|
ITEM
11.
|
37
|
|
|
|
|
ITEM
12.
|
38
|
|
|
|
|
ITEM
13.
|
39
|
|
|
|
|
ITEM
14.
|
40
|
|
41
|
2005
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
2006
First
Quarter
Second
Quarter Third
Quarter
Fourth
Quarter
|
High
3.55
3.25
3.00
3.00
3.19
2.00
|
Low
0.12
2.75
1.50
1.26
1.51
0.49
|
BIO-MATRIX
SCIENTIFIC GROUP, INC. AND SUBSIDIARY
|
(FORMERLY
TASCO INTERNATIONAL, INC.)
|
(A
Development Stage Company)
|
Consolidated
Balance Sheets
|
|
As of
|
As
of
|
||||||
|
September
30,
|
September
30,
|
||||||
|
2006
|
2005
|
||||||
ASSETS
|
|
|
||||||
Current
Assets
|
|
|
||||||
Cash
|
$ |
22,641
|
$ |
-
|
||||
Prepaid
expenses
|
20,207
|
-
|
||||||
Total
Current Assets
|
42,848
|
-
|
||||||
Property
& Equipment, net
|
340,557
|
-
|
||||||
Other
Asset-Security deposit
|
29,127
|
-
|
||||||
TOTAL
ASSETS
|
$ |
412,532
|
$ |
-
|
||||
|
||||||||
LIABILITIES
& STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
Current
Liabilities
|
||||||||
Accounts
payable
|
$ |
91,079
|
$ |
1,743
|
||||
Loan
from former parent
|
1,195,196
|
-
|
||||||
Notes
payable
|
148,952
|
-
|
||||||
Accrued
taxes
|
16,460
|
-
|
||||||
Accrued
interest
|
1,368
|
-
|
||||||
Total
Current Liabilities
|
1,453,055
|
1,743
|
||||||
TOTAL
LIABILITIES
|
1,453,055
|
1,743
|
||||||
|
||||||||
Stockholders'
Equity (Deficit)
|
||||||||
|
||||||||
Preferred
stock, ($.0001 par value authorized 20,000,000 shares authorized;
none
issued and outstanding.)
|
-
|
-
|
||||||
Common
stock, ($.0001 par value authorized 80,000,000 shares authorized;
13,385,000 and 12,780,000 shares issued and outstanding as of September
30, 2006 and 2005)
|
1,339
|
1,278
|
||||||
Additional
paid-in capital
|
30,375,584
|
31,895
|
||||||
Deficit
accumulated during development stage
|
(31,417,446 | ) | (34,916 | ) | ||||
Total
Stockholders' Equity (Deficit)
|
(1,040,523 | ) | (1,743 | ) | ||||
|
||||||||
TOTAL
LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)
|
$ |
412,532
|
$ |
-
|
BIO-MATRIX
SCIENTIFIC GROUP, INC. AND SUBSIDIARY
|
||||||||||||
(FORMERLY
TASCO INTERNATIONAL, INC.)
|
||||||||||||
(A
Development Stage Company)
|
||||||||||||
Consolidated
Statements of Operations
|
||||||||||||
|
Year
Ended
September
30,
2006
|
Year
Ended
September
30,
2005
|
October
6, 1998
(inception)
through
September
30,
2006
|
|||||||||
|
|
|
|
|||||||||
Revenues
|
|
|
|
|||||||||
Revenues
|
$ |
-
|
$ |
-
|
$ |
1,000
|
||||||
|
||||||||||||
Total
Revenues
|
-
|
-
|
1,000
|
|||||||||
|
||||||||||||
Cost
and expenses
|
||||||||||||
Research
and development
|
27,675
|
27,675
|
||||||||||
General
and administrative
|
790,754
|
6,667
|
826,695
|
|||||||||
Depreciation
and amortization
|
333
|
333
|
||||||||||
Consulting
and professional fees
|
790,635
|
790,635
|
||||||||||
Impairment
of goodwill and intangible assets
|
29,777,222
|
-
|
29,777,222
|
|||||||||
|
||||||||||||
Total
cost and Expenses
|
31,386,619
|
6,667
|
31,422,560
|
|||||||||
|
||||||||||||
Other
Income & (Expenses)
|
||||||||||||
Cancellation
of debts
|
5,443
|
5,443
|
||||||||||
Interest
income
|
14
|
39
|
||||||||||
Interest
expense
|
(1,368 | ) |
-
|
(1,368 | ) | |||||||
|
||||||||||||
Total
Other Income & (Expenses)
|
4,089
|
-
|
4,114
|
|||||||||
|
||||||||||||
Net
Loss
|
$ | (31,382,530 | ) | $ | (6,667 | ) | $ | (31,417,446 | ) | |||
|
||||||||||||
Basic
loss per share
|
$ | (2.45 | ) | $ | (0.00 | ) | ||||||
|
||||||||||||
Weighted
average number of
|
||||||||||||
common
shares outstanding
|
12,820,493
|
12,780,000
|
||||||||||
|
BIO-MATRIX
SCIENTIFIC GROUP, INC. AND SUBSIDIARY
|
||||||||||||||||||||
(FORMERLY
TASCO INTERNATIONAL, INC.)
|
||||||||||||||||||||
(A
Development Stage Company)
|
||||||||||||||||||||
Consolidated
Statements of Changes in Stockholders' Equity
(Deficit)
|
||||||||||||||||||||
From
October 6, 1998 (inception) through September 30,
2006
|
||||||||||||||||||||
|
Common
Stock
|
Common
Stock
Amount
|
Additional
Paid
- in
Capital
|
Deficit
Accumulated
During
Development
Stage
|
Total
|
|||||||||||||||
|
|
|
|
|
|
|||||||||||||||
Stock
issued for cash on October 6,
|
|
|
|
|
|
|||||||||||||||
1998
@ $0.0001 per share
|
1,000,000
|
$ |
100
|
$ | (90 | ) | $ |
-
|
$ |
10
|
||||||||||
|
||||||||||||||||||||
Stock
issued for cash on October 9,
|
||||||||||||||||||||
1998
@ $0.0001 per share
|
1,300,000
|
130
|
1,170
|
-
|
1,300
|
|||||||||||||||
|
||||||||||||||||||||
Stock
issued for cash on October 12,
|
||||||||||||||||||||
1998
@ $0.0001 per share
|
190,000
|
19
|
171
|
-
|
190
|
|||||||||||||||
|
||||||||||||||||||||
Stock
issued for cash on April 1,
|
||||||||||||||||||||
1999
@ $0.0001 per share
|
290,000
|
29
|
261
|
-
|
290
|
|||||||||||||||
|
||||||||||||||||||||
Net
loss, October 6, 1998 (inception)
|
||||||||||||||||||||
through
September 30, 1999
|
(295 | ) | (295 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 30, 1999
|
2,780,000
|
278
|
1,512
|
(295 | ) |
1,495
|
||||||||||||||
|
||||||||||||||||||||
Stock
issued for cash on October 19,
|
||||||||||||||||||||
1999
@ $0.01 per share
|
10,000,000
|
1,000
|
9,000
|
10,000
|
||||||||||||||||
|
||||||||||||||||||||
Net
loss, October 1, 1999 through
|
||||||||||||||||||||
September
30, 2000
|
(367 | ) | (367 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 30, 2000
|
12,780,000
|
1,278
|
10,512
|
(662 | ) |
11,128
|
||||||||||||||
|
||||||||||||||||||||
Net
loss, October 1, 2000 through
|
||||||||||||||||||||
September
30, 2001
|
(11,028 | ) | (11,028 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 30, 2001
|
12,780,000
|
1,278
|
10,512
|
(11,690 | ) |
100
|
||||||||||||||
|
||||||||||||||||||||
Net
loss, October 1, 2001 through
|
||||||||||||||||||||
September
30, 2002
|
(4,257 | ) | (4,257 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 31, 2002
|
12,780,000
|
1,278
|
10,512
|
(15,947 | ) | (4,157 | ) | |||||||||||||
|
||||||||||||||||||||
Net
loss, October 1, 2002 through
|
||||||||||||||||||||
September
30, 2003
|
(4,328 | ) | (4,328 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 30, 2003
|
12,780,000
|
1,278
|
10,512
|
(20,275 | ) | (8,485 | ) | |||||||||||||
|
||||||||||||||||||||
Contributed
capital
|
12,362
|
12,362
|
||||||||||||||||||
|
||||||||||||||||||||
Net
loss, October 1, 2003 through
|
||||||||||||||||||||
September
30, 2004
|
(7,974 | ) | (7,974 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 30, 2004
|
12,780,000
|
1,278
|
22,874
|
(28,249 | ) | (4,097 | ) | |||||||||||||
|
||||||||||||||||||||
Contributed
capital
|
9,021
|
9,021
|
||||||||||||||||||
|
||||||||||||||||||||
Net
loss, October 1, 2004 through
|
||||||||||||||||||||
September
30, 2005
|
(6,667 | ) | (6,667 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 30, 2005
|
12,780,000
|
$ |
1,278
|
$ |
31,895
|
$ | (34,916 | ) | $ | (1,743 | ) | |||||||||
|
||||||||||||||||||||
Stock
cancelled June 13, 2006
|
(10,000,000 | ) | (1,000 | ) |
-
|
(1,000 | ) | |||||||||||||
|
||||||||||||||||||||
Stock
issued June 13, 2006
|
10,000,000
|
1,000
|
28,999,000
|
29,000,000
|
||||||||||||||||
|
||||||||||||||||||||
Stock
issued for services
|
305,000
|
31
|
759,719
|
759,750
|
||||||||||||||||
|
||||||||||||||||||||
Stock
issued for compensation
|
300,000
|
30
|
584,970
|
585,000
|
||||||||||||||||
|
||||||||||||||||||||
Net
loss, October 1, 2005 through
|
||||||||||||||||||||
September
30, 2006
|
(31,382,530 | ) | (31,382,530 | ) | ||||||||||||||||
|
||||||||||||||||||||
Balance,
September 30, 2006
|
13,385,000
|
$ |
1,339
|
$ |
30,375,584
|
$ | (31,417,446 | ) | $ | (1,040,523 | ) |
BIO-MATRIX
SCIENTIFIC GROUP, INC. AND SUBSIDIARY
|
(FORMERLY
TASCO INTERNATIONAL, INC.)
|
(A
Development Stage Company)
|
Consolidated
Statements of Cash Flows
|
|
Year
Ended
September
30,
2006
|
Year
Ended
September
30,
2005
|
October
6, 1998
(inception)
through
September
30,
2006
|
|||||||||
|
|
|
||||||||||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|||||||||
Net
(loss)
|
$ | (31,382,530 | ) | $ | (6,667 | ) | $ | (31,417,446 | ) | |||
Adjustments
to reconcile net loss to net cash (used in) provided
|
||||||||||||
by
operating activities:
|
||||||||||||
Impairment
of goodwill and intangible asset
|
29,777,222
|
29,777,222
|
||||||||||
Depreciation
expense
|
333
|
-
|
333
|
|||||||||
Stock
issued for compensation
|
585,000
|
-
|
585,000
|
|||||||||
Stock
issued for services
|
759,750
|
-
|
759,750
|
|||||||||
Cancellation
of debts
|
(5,443 | ) | (5,443 | ) | ||||||||
Changes
in operating assets and liabilities:
|
||||||||||||
(Increase)
decrease in prepaid expenses
|
(20,207 | ) |
-
|
(20,207 | ) | |||||||
Increase
(Decrease) in Accounts Payable
|
89,336
|
(2,669 | ) |
91,079
|
||||||||
Increase
(Decrease) in Accrued Expenses
|
17,828
|
-
|
17,828
|
|||||||||
(
Increase) Decrease in Deposits
|
(29,127 | ) |
-
|
(29,127 | ) | |||||||
|
||||||||||||
Net
Cash Provided by (Used in) Operating
Activities
|
(207,838 | ) | (9,336 | ) | (241,011 | ) | ||||||
|
||||||||||||
CASH
FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
Purchases
of fixed assets
|
(340,890 | ) |
-
|
(340,890 | ) | |||||||
Purchases
of Intangible assets
|
(29,777,222 | ) |
-
|
(29,777,222 | ) | |||||||
|
||||||||||||
Net
Cash Provided by (Used in) Investing
Activities
|
(30,118,112 | ) |
-
|
(30,118,112 | ) | |||||||
|
||||||||||||
CASH
FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
Common
stock issued for cash
|
-
|
1,278
|
||||||||||
Additional
paid in Capital
|
29,004,443
|
9,021
|
29,036,338
|
|||||||||
Principal
borrowings on notes
|
148,952
|
-
|
148,952
|
|||||||||
Net
borrowings from related parties
|
1,195,196
|
-
|
1,195,196
|
|||||||||
|
||||||||||||
Net
Cash Provided by (Used in) Financing
Activities
|
30,348,591
|
9,021
|
30,381,764
|
|||||||||
|
||||||||||||
Net
Increase (Decrease) in Cash
|
22,641
|
(315 | ) |
22,641
|
||||||||
|
||||||||||||
Cash
at Beginning of Year
|
-
|
315
|
-
|
|||||||||
|
||||||||||||
Cash
at End of Year
|
$ |
22,641
|
$ |
-
|
22,641
|
|||||||
Supplemental
Cash Flow Disclosures:
|
||||||||||||
Cash
paid during period for interest
|
$ |
-
|
$ |
-
|
$ |
-
|
||||||
Cash
paid during period for taxes
|
$ |
800
|
$ |
800
|
$ |
800
|
||||||
|
||||||||||||
Significant
non cash disclosure items:
|
-
|
|||||||||||
Stock
issued for services and compensation
|
1,344,750
|
1,344,750
|
||||||||||
Increase
in goodwill and intangible assets
|
29,777,222
|
29,777,222
|
|
|
2006
|
|
|
Acquisition
cost:
|
|
|
|
|
Production
Equipment
|
|
US$
|
93,315
|
|
Production
Cleanroom
|
|
|
56,917
|
|
Leasehold
improvement
|
|
|
185,482
|
|
Office
equipment
|
|
|
3,057
|
|
Computer
|
|
|
2,668
|
|
Subtotal
|
|
|
341,439
|
|
Less
accumulated depreciation
|
|
|
882
|
|
Total
|
|
US$
|
340,557
|
|
|
As
of September 30, 2006
|
|||
|
|
|||
Deferred
tax assets:
|
|
|||
Net
operating tax carry forwards
|
$ |
10,989,122
|
||
Other
|
0
|
|||
|
||||
Gross
deferred tax assets
|
10,989,122
|
|||
Valuation
allowance
|
(10,989,122 | ) | ||
|
||||
Net
deferred tax assets
|
$ |
0
|
1998
Net Operating Loss
|
|
$
|
(295
|
)
|
1999
Net Operating Loss
|
|
|
(367
|
)
|
2000
Net Operating Loss
|
|
|
(11,028
|
)
|
2001
Net Operating Loss
|
|
|
(4,257
|
)
|
2002
Net Operating Loss
|
|
|
(4,328
|
)
|
2003
Net Operating Loss
|
|
|
(7,974
|
)
|
2004
Net Operating Loss
|
|
|
(6,667
|
)
|
2005
Net Operating Loss
|
|
|
(31,382,530
|
)
|
|
|
|
|
|
Net
Operating Loss
|
|
$
|
(31,417,
446
|
)
|
2006
|
$
227,739
|
2007
|
$
234,562
|
2008
|
$
241,611
|
2009
|
$
248,864
|
2010
|
$
234,377
|
|
|
|
Number
of
|
|
|
|
|
Shares
|
|
Twelve
months ended September 30, 2006:
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
605,000*
|
|
|
|
|
|
|
Remaining
shares available for issuance under the Plan as of September 30,
2006
|
|
|
895,000
|
|
August
23, 2007
August
24, 2007
August
30, 2007
August
30, 2007
September
5, 2007
September
7, 2007
September
12, 2007
September
13, 2007
September
13, 2007
September
21, 2007
September
28, 2007
September
28, 2007
October
5, 2007
October
11, 2007
October
11, 2007
October
12, 2007
October
18, 2007
November
8, 2007
November
9, 2007
|
$23,683.00
$16,667.21
$
7,077.59
$26,122.00
$
787.50
$
7,269.87
$
1,900.00
$12,085.72
$
6,128.93
$
2,200.00
$
6,075.50
$28,754.53
$23,751.63
$14,000.00
$
6,120.57
$
982.12
$
7,186.15
$52,051.90
$
3,900.00
|
Name
|
|
|
Age
|
|
|
Position
|
|
David
R. Koos
|
|
|
47
|
|
|
Chairman
of the Board of Directors, President, CEO, Secretary, and Acting
CFO
|
|
Brian
Pockett
|
|
|
53
|
|
|
Vice
President and COO, Director
|
|
Position:
|
Company
Name:
|
Employment
Dates:
|
|
|
|
Chairman,
President, CEO and Acting CFO
|
Bio-Matrix
Scientific Group,
Inc.
|
June
14, 2006 (Chairman) to Present
June
19, 2006 (President, CEO and Acting CFO)
June
19, 2006(Secretary) to Present
|
|
|
|
Chairman,
Chief Executive Officer, Secretary & Acting Chief Financial
Officer
|
Frezer
Inc.
|
May
2, 2005 to Present
|
|
|
|
Chairman,
Chief Executive Officer, Secretary & Acting Chief Financial
Officer
|
BMXP
Holdings, Inc.
BMSG
|
December
6, 2004 to Present
|
|
|
|
Managing
Director & President
|
Cell
Source Research Inc.
|
December
5, 2001 to Present
|
|
|
|
Managing
Director & President
|
Venture
Bridge Inc.
|
November
21, 2001 to Present
|
|
|
|
Member
of the Board of Directors, Chief Financial Officer &
Secretary
|
Cell
Bio-Systems Inc.
(New
York)
|
July
17, 2003 to December 1, 2003
|
|
|
|
Registered
Representative
|
Amerivet
Securities Inc.*
|
March
31, 2004 to Present
(Previously
employed: November, 2000 to May,
2002)
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Vice
President, COO and Director
|
Bio-Matrix
Scientific Group, Inc.
|
June
19, 2006 (Vice President and COO) to Present
June
14, 2006 (Director) to Present
|
Managing
Director & Chief Operating Officer
|
Frezer
Inc.
|
May
2, 2005 to Present
|
Managing
Director & Chief Operating Officer
|
BMXP
Holdings, Inc.
BMSG
|
December
6, 2004 to Present
|
Business
Development Consultant
|
Cell
Bio-Systems Inc.
(New
York)
|
April
1, 2003 to November 30, 2004
|
Sales
& Marketing Consultant
|
North
County Times
|
July
1, 2002 to March 15, 2003
|
Independent
Magazine Contractor
|
DaVinci
|
January
1, 2000 to June 30, 2002
|
Independent
Magazine Contractor
Independent
Magazine Contractor
|
Digital
Diner
Shock
Waves
|
January
1, 2000 to June 30, 2002
January
1, 2000 to June 30, 2002
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Chief
Scientific Advisor
|
Bio-Matrix
Scientific Group, Inc.
|
August
9, 2006 to present
|
President
|
Frezer
Inc., San Diego , CA
|
May
2, 2005 to present
|
President
|
BMXP
Holdings, Inc.. San Diego, CA
|
March,
2005 to present
|
Consultant
in Biotechnology
|
Self
employed, Tarpon Springs FL
|
July,
2004 to March, 2005
|
Laboratory
and Scientific Director
|
Cryo-Cell
International Inc, Clearwater, FL
|
April,
1999 to June, 2004
|
SUMMARY
COMPENSATION TABLE
|
|||||||||
Name
and principal position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards ($)
(a)
|
Option
Awards ($)
|
Non-Equity
Incentive Plan Compensation ($)
|
Nonqualified
Deferred Compensation Earnings ($)
|
All
Other Compensation ($)
|
Total
($)
|
Dr.
David Koos
Chairman,
CEO and President
|
October
1, 2005 to September 30, 2006
|
0
|
0
|
$292,500
|
0
|
0
|
0
|
0
|
$292,500
|
Mr.
Brian Pockett
Vice
President, COO and Director
|
October
1, 2005 to September 30, 2006
|
0
|
0
|
$292,500
|
|
|
0
|
0
|
$292,500
|
Title
of Class
|
Name
and Address of Beneficial Owner
|
Amount
and Nature of Beneficial Owner
|
Percent
of Class
|
Common
|
David
R. Koos (a)
C/o
Bio-Matrix Scientific Group, Inc
8885
REHCO RD.SAN DIEGO CA 92121
|
11,591,935
|
70
|
Common
|
Brian
Pockett (a)
C/o
Bio-Matrix Scientific Group, Inc
8885
REHCO RD.SAN DIEGO CA 92121
|
11,591,935
|
70
|
Common
|
BMXP
Holdings, Inc.
|
11,391,935
|
69
|
Common
|
All
Officers and Directors
As
a
Group(a)
|
11,791,935
|
72
|
EXHIBIT
NUMBER
|
|
|
DESCRIPTION
|
|
|
|
|
|
|
31.1**
|
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
32.1**
|
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT
|
|
31.2**
|
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
32.2**
|
|
|
CERTIFICATION
BY CFO PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT
|
|
31.3
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|||
31.4
|
CERTIFICATION
BY CFO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|||
20.1
|
|
|
REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ARMANDO C IBARRA
OFTHE
BALANCE SHEET OF TASCO INTERNATIONAL, INC. AS OF SEPTEMBER 30, 2005,
AND
THE RELATED STATEMENTS OF OPERATIONS, CHANGES IN STOCKHOLDERS' EQUITY,
AND
CASH FLOWS FOR THE PERIOD OF OCTOBER 6, 1998 (INCEPTION) THROUGH
SEPTEMBER
30, 2005 (YEAR-END)DATED DECEMBER 28, 2005*
|
|
23.1**
|
|
|
CONSENT
OF ARMANDO IBARRA,CPA
|
|
|
Period
beginning Oct1, 2005 and ending September 30, 2006
|
|||
|
|
|||
Audit
Fees
|
$ |
5800
|
||
Audit
Related Fees
|
4670
|
|||
Tax
Fees
|
0
|
|||
All
Other Fees
|
75
|
|||
|
||||
|
$ |
10545
|
|
|
|||
|
Period
beginning Oct1, 2005 and ending September 30, 2006
|
|||
|
|
|||
Audit
Fees
|
$ |
0
|
||
Audit
Related Fees
|
2500
|
|||
Tax
Fees
|
0
|
|||
All
Other Fees
|
0
|
|||
|
||||
|
$ |
2500
|